Stig Jarle Pettersen

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

Nestlé Deutschland AG makes ice creams and frozen desserts. It also offers baby, sports, breakfast, ready to mix kitchen helper, drinks, and sweets. The company was founded in 1839 and is headquartered in Frankfurt am Main, Germany.

Oboronprom United Industrial Corp. JSC operates as a holding company with interests in civilian and military helicopters manufacturing. It operates as a diversified industrial-investment group in the engineering and technologies sectors. The company was founded in 2002 and is headquartered in Moscow, the Russian Federation.

BC Brandenburg Capital GmbH (BC GmbH) is a venture capital investment firm and a majority-owned subsidiary of ILB-Investitionsbank des Landes Brandenburg, the promotional bank for the State of Brandenburg in the east of Germany. BC GmbH was established in 2000 and is headquartered in Potsdam near Berlin, with an office in Frankfurt an der Oder, on the German-Polish border. The firm manages a series of venture capital funds, and invests a combination of private and public funds.

BFB Brandenburg Kapital GmbH invests in small and middle market technology orientated companies located in the state of Brandenburg, Germany, in the form of direct investments and silent partnership. It invests only together with at least one private investor.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

Generium ZAO is a biotechnology company based in Moscow, Russian Federation. The company is a leader in the Russian pharmaceutical market for orphan diseases and has its own R&D park capable of developing any biotech product from molecule design to commercial production. Generium's manufacturing facilities comply with international GMP standards and produce a unique variety of biotech products, including biomedical cell products. The private company offers job opportunities and is dedicated to biotechnological research and development.

International Biotech Center Generium, LLC operates as a Russian scientific research company.

Part of co.don AG, co.don schweiz GmbH operates as a Swiss biopharmaceutical company. The company is based in Zug, Switzerland. The CEO of the company is Tilmann Heinrich Johannes Bur.

Oncotartis LLC engages in the development of anti-cancer drugs. It develops drugs to treat prostrate and breast cancer, melanoma, leukemia and lymphoma. The company was founded by Alexander Polinsky, Andrei Gudkov, and Olga Chernova in 2011 and is headquartered in Buffalo, NY.